NORDIMET Trademark

Trademark Overview

On Monday, November 15, 2021, a trademark application was filed for NORDIMET with the United States Patent and Trademark Office. The USPTO has given the NORDIMET trademark a serial number of 97124619. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, March 17, 2025. This trademark is owned by Nordic Group B.V.. The NORDIMET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, autoimmune diseases and ectopic pregnancy; pharmaceutical preparations for medical abortions
nordimet

General Information

Serial Number97124619
Word MarkNORDIMET
Filing DateMonday, November 15, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, March 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer, autoimmune diseases and ectopic pregnancy; pharmaceutical preparations for medical abortions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNordic Group B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHoofddorp 2132WT
NL
Party NameNordic Group B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHoofddorp 2132WT
NL

Trademark Events

Event DateEvent Description
Thursday, November 18, 2021NEW APPLICATION ENTERED
Friday, November 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Monday, August 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 19, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 19, 2023SOU EXTENSION 1 FILED
Wednesday, April 19, 2023SOU EXTENSION 1 GRANTED
Friday, April 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 17, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 17, 2023SOU EXTENSION 2 FILED
Friday, November 17, 2023SOU EXTENSION 2 GRANTED
Tuesday, November 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2024SOU EXTENSION 3 FILED
Monday, May 13, 2024SOU EXTENSION 3 GRANTED
Monday, May 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 19, 2024SOU EXTENSION 4 FILED
Tuesday, November 19, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 19, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 19, 2025SOU EXTENSION 4 GRANTED
Thursday, February 20, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 13, 2025SOU EXTENSION 5 FILED
Thursday, March 13, 2025SOU TEAS EXTENSION RECEIVED
Monday, March 17, 2025SOU EXTENSION 5 GRANTED
Tuesday, March 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

nordimet pharmaceutical preparations pregnancy abortions ectopic medical autoimmune treatment cancer diseases